What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry

What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry

After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore — a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Olin Business School experts Patrick Aguilar and Peter Boumgarden.
Older Stories